openPR Logo
Press release

Hemostasis Products Market 2016 - 2024; Over this period, the market for advanced hemostats is expected to rise at a 6.9% CAGR, while segment of infusible hemostats will exhibit a meagre 07% CAGR

01-12-2017 12:18 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Hemostasis Products Market 2016 - 2024; Over this period,

This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global hemostasis products market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global hemostasis products market.

Read Full Report: http://www.transparencymarketresearch.com/hemostasis-products-market.html

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Based on product type, the global hemostasis products market has been segmented into topical hemostasis products (collagen, oxidized regenerated cellulose, gelatin, and polysacchride), infusible hemostasis products (platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex), and advanced hemostasis products (flowable, thrombin, fibrin, and synthetic sealants). The market has been further studied from the point of view of major applications of hemostasis products.

Based on application, the market has been categorized into trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Based on end-user, the market has been segmented into hospitals and clinics.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13880

Geographically, the global hemostasis products market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S, Canada, the U.K., Germany, Japan, China, Brazil, and Mexico. The report also profiles major players in the hemostasis products market based on various attributes such as company overview, financial overview, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., C. R. Bard, Inc., CSL Behring LLC, Grifols, S.A., HemCon Medical Technologies, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, and Pfizer, Inc.

For this study, the global hemostasis products market has been segmented as follows:

Hemostasis Products Market, by Product type

Topical Hemostasis
Collagen
Oxidized Regenerated Cellulose
Gelatin
Polysaccharide
Infusible Hemostasis
Platelet Concentrates from Donor Blood
FVIII Derived from Blood
Fresh Frozen Plasma
Prothrombin Complex
Advanced Hemostasis
Flowable
Thrombin
Fibrin
Synthetic Sealants
Hemostasis Products Market, by Application

Trauma
Surgery
Hemophilia
Myocardial Infarction
Stroke
Thrombosis
Hemostasis Products Market, by End-user

Hospitals
Clinics
Hemostasis Products Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Rest of the World

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemostasis Products Market 2016 - 2024; Over this period, the market for advanced hemostats is expected to rise at a 6.9% CAGR, while segment of infusible hemostats will exhibit a meagre 07% CAGR here

News-ID: 411365 • Views:

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for Hemostasis

Hemostasis Diagnostics Market Forecast Overview, 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Hemostasis Diagnostic Devices And Equipment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $9.85 billion
Hemostasis Valves Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Hemostasis Valves Market Size Projected to Reach USD 255 Billion by 2030, Growing at 5.80% CAGR Ameco Research is proud to announce the launch of its latest market research report, Hemostasis Valves Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Hemostasis Diagnostics Market: Global Industry Analysis 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Diagnostics Market: Global Markets & Advanced Technologies
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Products Market: Applications and Global Markets
This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study
Predictions for 2024: Hemostasis Products Market
The top four vendors operating in the global hemostasis products market, including Ethicon, Pfizer Inc., Baxter International, Inc., and CR Bard, Inc., accounted for a share of nearly 41% in the market in 2015, states Transparency Market Research in a recent report. In the seemingly fragmented market, where small- and medium-scale vendors accounted for over 59% in the overall market in the 2015, a large number of these players provided